Immunovant (IMVT)
(Delayed Data from NSDQ)
$31.44 USD
-2.59 (-7.61%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $31.74 +0.30 (0.95%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
IMVT 31.44 -2.59(-7.61%)
Will IMVT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMVT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IMVT
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report?
IMVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why
Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound?
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Other News for IMVT
Roivant Provides Update on Graves? Disease Development Program
Immunovant stock falls 8% amid Graves' disease program update
Immunovant Provides Update on Graves? Disease Development Program
Notable Friday Option Activity: IMVT, AMD, JPM
Immunovant to Host Graves? Disease Program Update on September 9, 2024